Status:
COMPLETED
The Response to Atropine Drops (RAD) Study
Lead Sponsor:
Ohio State University
Conditions:
Myopia
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this study is to examine the comfort of giving low concentration atropine eye drops.
Detailed Description
After being informed about the study and potential risks, all participants giving written informed consent will answer questions about themselves and complete a 12-question survey about the need for d...
Eligibility Criteria
Inclusion
- 18 years and older
Exclusion
- None
Key Trial Info
Start Date :
May 19 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05199597
Start Date
May 19 2022
End Date
June 15 2022
Last Update
December 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ohio State University College of Optometry
Columbus, Ohio, United States, 43210-1240